Персонализированный подход к выбору контрацептива: взвешиваем все за и против


Цитировать

Полный текст

Аннотация

В статье представлены последние данные о рисках развития осложнений на фоне применения комбинированных оральных контрацептивов, а также освещены лечебные эффекты применения гормональных контрацептивов.

Об авторах

Ю Э Доброхотова

ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России

д-р мед. наук, проф., зав. каф. акушерства и гинекологии лечебного фак-та ФГБОУ ВО «РНИМУ им. Н.И.Пирогова» 117997, Россия, Москва, ул. Островитянова, д. 1

Е И Боровкова

ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России

Email: katyanikitina@mail.ru
д-р мед. наук, проф. каф. акушерства и гинекологии лечебного фак-та ФГБОУ ВО «РНИМУ им. Н.И.Пирогова» 117997, Россия, Москва, ул. Островитянова, д. 1

Список литературы

  1. FDA Office of Surveillance and Epidemiology. Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
  2. US Food and Drug Administration. Birth Control Pills Containing Drospirenone: Label Change - Products may be associated with a higher risk for blood clots. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm299605.h..
  3. Petitti D.B. Clinical practice. Combination estrogen - progestin oral contraceptives. N Engl J Med 2003; 349: 1443.
  4. Rosenberg M.J, Waugh M.S, Meehan T.E. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 1995; 51: 283.
  5. ESHRE Capri Workshop Group, Collins J, Crosignani P.G. Endometrial bleeding. Hum Reprod Update 2007; 13: 421.
  6. Endrikat J, Gerlinger C, Plettig K et al. A meta - analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low - dose oral contraceptive use. Gynecol Endocrinol 2003; 17: 107.
  7. Rosenberg M.J, Waugh M.S, Stevens C.M. Smoking and cycle control among oral contraceptive users. Am J Obstet Gynecol 1996; 174:628.
  8. Lawrie T.A, Helmerhorst F.M, Maitra N.K et al. Types of progestogens in combined oral contraception: effectiveness and side - effects. Cochrane Database Syst Rev 2011: CD004861.
  9. Jacobs H.S, Knuth U.A, Hull M.G, Franks S. Post - "pill" amenorrhoea - cause or coincidence? Br Med J 1977; 2: 940.
  10. Davis A.R, Kroll R, Soltes B et al. Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive. Fertil Steril 2008; 89: 1059.
  11. Chasan-Taber L, Stampfer M.J. Epidemiology of oral contraceptives and cardiovascular disease. Ann Intern Med 1998; 128: 467.
  12. Stadel B.V. Oral contraceptives and cardiovascular disease (first of two parts). N Engl J Med 1981; 305: 612.
  13. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet 1981; 1: 541.
  14. Lidegaard Ø, Løkkegaard E, Jensen A et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366: 2257.
  15. Croft P, Hannaford P.C. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. BMJ 1989; 298: 165.
  16. Rosenberg L, Palmer J.R, Rao R.S, Shapiro S. Low - dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 2001; 161: 1065.
  17. Petitti D.B. Hormonal contraceptives and arterial thrombosis - not risk - free but safe enough. N Engl J Med 2012; 366: 2316.
  18. Curtis K.M, Chrisman C.E, Peterson H.B, WHO Programme for Mapping Best Practices in Reproductive Health. Contraception for women in selected circumstances. Obstet Gynecol 2002; 99: 1100.
  19. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case - control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1996; 348: 498.
  20. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case - control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1996; 348: 505.
  21. Heinemann L.A, Lewis M.A, Thorogood M et al. Case - control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women. BMJ 1997; 315: 1502.
  22. Petitti D.B, Sidney S, Bernstein A et al. Stroke in users of low - dose oral contraceptives. N Engl J Med 1996; 335: 8.
  23. Schwartz S.M, Siscovick D.S, Longstreth W.T Jr et al. Use of low - dose oral contraceptives and stroke in young women. Ann Intern Med 1997; 127: 596.
  24. Kemmeren J.M, Tanis B.C, van den Bosch M.A et al. Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 2002; 33: 1202.
  25. Bushnell C, Mc Cullough L.D, Awad I.A et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 1545.
  26. Lidegaard Ø, Løkkegaard E, Svendsen A.L, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow - up study. BMJ 2009; 339: b2890.
  27. Van Hylckama Vlieg A, Helmerhorst F.M, Vandenbroucke J.P et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case - control study. BMJ 2009; 339: b2921.
  28. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of combined oral contraceptives and risk of venous thromboembolism: nested case - control studies using the QResearch and CPRD databases. BMJ 2015; 350: h2135.
  29. de Bastos M, Stegeman B.H, Rosendaal F.R et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev 2014: CD010813.
  30. Hannaford P.C, Selvaraj S, Elliott A.M et al. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 2007; 335: 651.
  31. Harlow S.D, Gass M, Hall J.E et al. Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012; 97: 1159.
  32. Bromberger J.T, Schott L.L, Kravitz H.M et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010; 67: 598.
  33. Randolph J.F.Jr, Zheng H, Sowers M.R et al. Change in follicle - stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011; 96: 746.
  34. Randolph J.F.Jr, Sowers M, Gold E.B et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003; 88: 1516.
  35. Van Voorhis B.J, Santoro N, Harlow S et al. The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol 2008; 112: 101.
  36. Gold E.B, Colvin A, Avis N et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 2006; 96: 1226.
  37. Greendale G.A, Derby C.A, Maki P.M. Perimenopause and cognition. Obstet Gynecol Clin North Am 2011; 38: 519.
  38. APGO educational series on women's health issues. Clinical management of abnormal uterine bleeding. Association of Professors of Gynecology and Obstetrics, 2006.
  39. Rimsza M.E. Dysfunctional uterine bleeding. Pediatr Rev 2002; 23: 227.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО "Консилиум Медикум", 2017

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).